Kventia Therapeutic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1008.76%
- Profit Growth 143.71%
- Ebitda 320.65%
- Net Worth 103.73%
- Total Assets 82.10%
About Kventia Therapeutic
Kventia Therapeutic Private Limited (KTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 19 March 2018 (Six years and 11 months 8 days old ). Its registered office is in Raipur, Chattisgarh, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kirti Patel and Vikas Chandrakar serve as directors at the Company.
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999CT2018PTC008436
- Company No.
008436
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at Kventia Therapeutic?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kirti Patel  | Director | 19-Mar-2018 | Current |
| Vikas Chandrakar | Director | 19-Mar-2018 | Current |
Financial Performance of Kventia Therapeutic.
Kventia Therapeutic Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1008.76% increase. The company also saw a substantial improvement in profitability, with a 143.71% increase in profit. The company's net worth Soared by an impressive increase of 103.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kventia Therapeutic?
Unlock access to Kventia Therapeutic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
K V Clinical Research Private LimitedKirti Patel and Vikas Chandrakar are mutual person
- Moxieheal Foundation
Kirti Patel and Vikas Chandrakar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kventia Therapeutic?
Unlock and access historical data on people associated with Kventia Therapeutic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kventia Therapeutic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kventia Therapeutic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.